An Anti-inflammatory Helps Prevent Heart Disease. And It's Only $200k Per Year!

[aquaman]

Drug Aimed at Inflammation May Lower Risk of Heart Disease and Cancer

The anti-inflammatory drug canakinumab "..can reduce the risk of heart attacks and strokes, and possibly lung cancer, in people who have already had one heart attack and are at high risk for another..."

And it only costs $200k per year.

canakinumab is owned by Novartis. And the study was paid for by... Novartis! Amazing.

I'm sure there's no other anti-inflammatory drug cheaper than $200k a year that could help

 

[aquaman]

The other twist: "But because the drug suppresses part of the immune system, it increases the risk of infections, including fatal ones. Deaths from infection in the study appeared to match lives saved by the drug, so there was no difference in overall mortality between the groups that got the drug and the placebo"!

 

[Tenacity]

I'm sure there's no other anti-inflammatory drug cheaper than $200k a year that could help

Like aspirin? Oh wait, that makes your brain bleed...

 

[Mito]

MMS: Error

CONCLUSIONS
Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering. (Funded by Novartis; CANTOS ClinicalTrials.gov number, NCT01327846.)